BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 83918)

  • 1. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
    Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
    Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 3. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological mechanisms of tube leukocyte adherence inhibition.
    Thomson DM; Grosser N
    Cancer Res; 1979 Feb; 39(2 Pt 2):576-81. PubMed ID: 83912
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
    Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
    Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of the human antitumor immune response to organ-specific neoantigens.
    Thomson DM; Phelan K; Scanzano R; Fink A
    Transplant Proc; 1981 Dec; 13(4):1952-4. PubMed ID: 6277060
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic diagnosis of malignant neoplasms. I].
    Shuster J; Thomson DM; Fuks A; Gold P
    Union Med Can; 1980 Jun; 109(6):902-9. PubMed ID: 7008310
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of cellular immunity to murine sarcoma virus-induced tumors by leukocyte adherence inhibition.
    Mortensen RF
    J Natl Cancer Inst; 1979 Jan; 62(1):157-63. PubMed ID: 214608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Human antitumor immunity according to leukocyte adherence inhibition test data].
    Riatsep VI; Kurtenkov OA; Nikitin IuG; Miliukhina LM
    Vopr Onkol; 1980; 26(8):3-8. PubMed ID: 6998116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific cellular immune responses in patients with malignant gliomas.
    Sheikh KM; Apuzzo ML; Weiss MH
    Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary and future prospects of leukocyte adherence inhibition.
    Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):660-2. PubMed ID: 367591
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific immunity in patients with carcinoma of the pancreas. Preliminary report].
    Mester M; Zuliani A; Scheinberg MA; Machado MC
    Rev Hosp Clin Fac Med Sao Paulo; 1983 Jun; 38(3):107-10. PubMed ID: 6364296
    [No Abstract]   [Full Text] [Related]  

  • 20. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.